These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2459520)

  • 41. Lymphocytes of healthy subjects and schizophrenic patients possess no high-affinity binding sites for spiroperidol.
    Rao ML; Deister A; Roth A
    Pharmacopsychiatry; 1990 Jul; 23(4):176-81. PubMed ID: 2381986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH; Dvorkin B; Klein PN
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [3H] spiroperidol binding to brain neurotransmitter receptors.
    Withy RM; Mayer RJ; Strange PG
    FEBS Lett; 1980 Apr; 112(2):293-5. PubMed ID: 6154601
    [No Abstract]   [Full Text] [Related]  

  • 44. Radioligand binding and autoradiographic analysis of dopamine receptors in the human heart.
    Amenta F; Gallo P; Rossodivita A; Ricci A
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):147-54. PubMed ID: 8386324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors.
    Frost JJ; Smith AC; Kuhar MJ; Dannals RF; Wagner HN
    Life Sci; 1987 Mar; 40(10):987-95. PubMed ID: 3821368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors.
    Mach RH; Jackson JR; Luedtke RR; Ivins KJ; Molinoff PB; Ehrenkaufer RL
    J Med Chem; 1992 Feb; 35(3):423-30. PubMed ID: 1531364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serotonin-S2 and dopamine-D2 receptors are the same size in membranes.
    Brann MR
    Biochem Biophys Res Commun; 1985 Dec; 133(3):1181-6. PubMed ID: 2935151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple fluorescent ligands for dopamine receptors. II. Visualization in neural tissues.
    Ariano MA; Kang HC; Haugland RP; Sibley DR
    Brain Res; 1991 May; 547(2):208-22. PubMed ID: 1884196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
    Bischoff S; Heinrich M; Sonntag JM; Krauss J
    Eur J Pharmacol; 1986 Oct; 129(3):367-70. PubMed ID: 3536532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex.
    Goldman-Rakic PS; Lidow MS; Gallager DW
    J Neurosci; 1990 Jul; 10(7):2125-38. PubMed ID: 2165520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [3H]-Spiroperidol labels dopamine receptors in membranes from rabbit mesenteric artery.
    Brodde OE; Gross G
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Apr; 311(3):249-54. PubMed ID: 7393340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of binding sites for [3H]spiroperidol.
    Luedtke RR; Molinoff PB
    Biochem Pharmacol; 1987 Oct; 36(19):3255-64. PubMed ID: 2959288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological characterization and autoradiographic localization of dopamine receptors in the human adrenal cortex.
    Amenta F; Chiandussi L; Mancini M; Ricci A; Schena M; Veglio F
    Eur J Endocrinol; 1994 Jul; 131(1):91-6. PubMed ID: 8038912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age related decrease in the density of dopamine D1 and D2 receptors in corpus striatum of rats.
    Hyttel J
    Pharmacol Toxicol; 1987 Aug; 61(2):126-9. PubMed ID: 3671327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increase of serotonin receptors in rat uterus induced by estradiol.
    Ichida S; Tokunaga H; Oda Y; Fujita N; Hirata A; Hata T
    J Biol Chem; 1983 Nov; 258(22):13438-43. PubMed ID: 6643435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding.
    Peroutka SJ; Snyder SH
    Science; 1980 Oct; 210(4465):88-90. PubMed ID: 6251550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats.
    De Blasi A; Mennini T
    Brain Res; 1982 Jun; 242(2):361-4. PubMed ID: 7116143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding of [3H]haloperidol to dopamine D2 receptors in the rat striatum.
    Tsuchihashi H; Sasaki T; Kojima S; Nagatomo T
    J Pharm Pharmacol; 1992 Nov; 44(11):911-4. PubMed ID: 1361536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential changes in central serotonin and dopamine receptors in spontaneous hypertensive rats.
    Chiu P; Rajakumar G; Chiu S; Kwan CY; Mishra RK
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):665-8. PubMed ID: 6531438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characteristics of the inhibition of ligand binding to serotonin receptors in rat brain membranes by verapamil.
    Adachi H; Shoji T
    Jpn J Pharmacol; 1986 Aug; 41(4):431-5. PubMed ID: 3773338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.